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The extraordinary increase of the elderly in developed countries underscore the importance of studies on ageing
and longevity and the need for the prompt spread of knowledge about ageing in order to satisfactorily decrease
the medical, economic and social problems associated to advancing years, because of the increased number of
individuals not autonomous and affected by invalidating pathologies.
Centenarians are equipped to reach the extreme limits of human life span and, most importantly, to show relatively
good health, being able to perform their routine daily life and to escape fatal age-related diseases. Thus, they are
the best example of extreme longevity, representing selected people in which the appearance of major age-related
diseases, such as cancer, and cardiovascular diseases among others, has been consistently delayed or escaped. To
discuss the relevance of genetics and life style in the attainment of longevity, five papers mostly focused on Italian
centenarians have been assembled in this series. The aim is to realize, through a” positive biology” approach (rather
than making diseases the central focus of research, “positive biology” seeks to understand the causes of positive
phenotypes, trying to explain the biological mechanisms of health and well-being) how to prevent and/or reduce
elderly frailty and disability.
Keywords: Ageing, Frailty, Longevity, “Positive Biology”Introduction
During the last century, life expectancy at birth rose by a
remarkable 30 years in Western countries and in Japan,
initially because of reductions in infant, child, and mater-
nal mortality and then because of declining mortality in
middle and old age. So, during the past century, humans
have gained more years of average life expectancy than
in the last 10,000 years: we are now living in a rapidly
ageing world. The sharp rise in life expectancy, coupled
to a steady decline in birth rates in all developed coun-
tries, has led to an unprecedented demographic revolu-
tion characterized by an explosive growth in the number
and proportion of older people. In 1900, about 40% of
babies born in Western countries were expected to live
beyond age 65. Today in these same countries more than
88% of all newborns will live past age 65 and at least
44% will live beyond age 85. The number of people aged
60 years or older exceeded 635 million in 2002, and is
expected to grow to nearly 2 billion by 2050. The pro-
portion of people aged 60 and over stands about 1 in 4
in many Western countries as well as in Japan. Should* Correspondence: calogero.caruso@unipa.it
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reproduction in any medium, provided the orthe present trend continues, this ratio is expected to
reach 1 in 3 by 2050. So, many countries have rising
ageing populations and are facing an increased preva-
lence of age-related diseases and increasing healthcare
costs, since the rapid rise in older people is accompanied
by an increase in the number of people with chronic
age-related diseases. However, the improvement in pub-
lic health has reduced the principal causes of mortality
in the elderly, allowing an increasing number of indivi-
duals to reach the maximum lifespan age. Indeed, around
the 1950s, in all industrialized countries, the progressive
decline of mortality in oldest old people has increased,
so that the number of centenarians has augmented about
20 times [1-6]. Nowadays it is reasonable to assume that
the total number of centenarians is more than three
hundred thousand people worldwide [7].
The increased ability to reach 100 years in industria-
lized countries over the last 150 years most likely reflects
a rise in life expectancy as a consequence of improve-
ments in diet and a reduced exposure to infection and
inflammation [1]. In favour of diet as a modulator of lon-
gevity, the Elderly Prospective Cohort Study identified a
reduced overall mortality among the elderly consuming a
modified Mediterranean diet in which saturated fatty
acids were substituted for monounsaturated ones [8] andLtd This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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longevity are characterized by close adherence to
Mediterranean diet [9]. The traditional Mediterranean
diet provides about 40% of calories from fat, mostly
monounsaturated and polyunsaturated fat [8]. Concerning
Japanese centenarians, traditional Okinawan diets provide
about 90% of calories from vegetables carbohydrate, there-
fore it is low in calories but nutritionally dense, particularly
with regard to vitamins, minerals, and phytonutrients [10].
Concerning inflammation, the reduction in lifetime
exposure to infectious diseases and other sources of
inflammation, the cohort mechanism, has been suggested
to contribute to the historical decline in old-age mortality,
suggesting long-life pathogen burden as the most import-
ant factor for age-related inflammation. Accordingly, some
studies have linked an individual exposure to past infec-
tion to levels of chronic inflammation and to increased
risk of heart attack, stroke, and cancer [11-14].
The extraordinary increase of the elderly in developed
countries underscore the importance of studies on age-
ing and longevity and the need for the prompt spread of
knowledge about ageing in order to satisfactorily de-
crease the medical, economic and social problems asso-
ciated to advancing years for the increase of the subjects
which are not autonomous and are affected by invalidat-
ing pathologies [15].
Recently, it has been pointed out that most biomedical
research should be termed ‘negative biology’, because the
study of disease is its central heart, reflecting the preva-
lence of pathology-oriented negative biology, so focusing
on the causes of pathology. By contrast, the Author
invites to focus on a different approach, named “positive
biology”. Rather than making diseases the central focus
of research, positive biology seeks to understand the
causes of positive phenotypes, trying to explain the bio-
logical mechanisms of health and well-being [16]. In par-
ticular, concerning our topic, this means to understand
why some individuals, i.e. the centenarians, have escaped
neonatal mortality, pre-antibiotic era diseases, and fatal
outcomes of age-related diseases, so leaving more than
100 years [17,18]. Investigating the biological mechanisms
underlying centenarian longevity, therefore, shows an
interesting conundrum for positive biology. The know-
ledge grew out of this approach could allow to modulate
the rate of ageing providing valuable information on the
lifestyle to achieve healthy ageing. In addition, studying
centenarians might supply important indications how to
build up drugs that can slow or delay ageing, with benefits
for those who are more vulnerable to disease and disability
[19,20].
The model of centenarians is not simply an additional
model with respect to well-studied organisms, since the
study of humans has revealed characteristics of ageing
and longevity as geographical and sex differences, role ofantigenic load and inflammation, which did not emerge
from studies in laboratory model systems and organisms.
So, scientists have focused their attention on centenar-
ians as optimal model to address the biological mechan-
isms of successful ageing [17,18].
Centenarians are equipped to reach the extreme limits
of human life span and, most importantly, to show rela-
tively good health, being able to perform their routine
daily life and to escape fatal age-related diseases. Thus,
they are the best example of extreme longevity, repre-
senting selected peope in which the appearance of major
age-related diseases, such as cancer, and cardiovascular
diseases among others, has been consistently delayed or
escaped [17,18].
The ageing process and longevity are multi-factorial
events. Genetic, epigenetic, stochastic and environmental
factors seem to have a crucial role in ageing and longevity.
As well known, life expectancy is a familial trait and lon-
gevity is determined by different factors. Epidemiological
evidence for a genetic component to variation in human
lifespan comes from twin studies and family studies. By
comparing life span in twins, researchers have found that
approximately 25% of the overall variation in human life-
span can be attributed to genetic factors, which become
more relevant for extreme longevity [21-24]. Conditioning
factors, that arise in the first part of life (socio-economic
state of parents, education and month of birth, which has
been found to reflect the environmental conditions during
the prenatal and early postnatal period), account for
another 25% of such variability; life circumstances at adult
and old age (including socio-economic status and medical
assistance) may account for about the remaining 50% [25].
In this context, the study of centenarian offspring, a
group of healthy elderly people with a familiar history of
longevity, might help gerontologists to better identify the
correlation between genetic profile and hope of a healthy
ageing. Previous studies have reported that centenarian
offspring, like their centenarian parents, have genetic and
immune system advantages, which reflect a minor risk to
develop major age-related diseases, such as cardiovascular
diseases, hypertension or diabetes mellitus as well as
cancer [26,27].
The series
To discuss the relevance of genetics and life style in the
attainment of longevity, five papers mostly focused on
Italian centenarians have been assembled in this series
with aim to understand, through a “positive biology”
approach, how to prevent and/or reduce elderly frailty
and disability.
As it is known, healthy ageing and longevity in humans
result from a number of factors, including genetic back-
ground, favorable environmental and social factors and
chance. So, in their paper Montesanto et al., discuss the
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the variation of quality of ageing and lifespan, including
the most promising candidate genes investigated so far.
Epigenetic modifications indicate the sum of heritable
changes, such as DNA methylation, histone modification
and miRNA expression, that affect gene expression with-
out changing the DNA sequence. So, they outlined some
recent advance in the epigenetic studies of ageing, as epi-
genetics, a bridge between genetics and environment,
might explain many aspects of ageing and longevity.
In their review, Ferrario et al,. point out that the gen-
etic origin of exceptional longevity and the more recently
observed environment-driven increase in the average age
of the population could possibly be explained by the
same genetic variants and environmentally modulated
mechanisms. The potential overlap of hits for environ-
mentally and genetically mediated predisposition for ex-
treme longevity in centenarians is highlighted by the
association of genetic variants of genes that regulate, or
that are regulated by, nutrient metabolism. They con-
clude that the adoption of innovative study designs com-
bined with novel genetic platforms and innovative
statistical methods hopefully will bring to the identifica-
tion of new intervention points at which to modulate
ageing and the diseases of ageing.
In their review, Balistreri et al., report their data gath-
ered for over 10 years in Sicilian centenarians. Based on
their findings, they suggest longevity as the result of an
optimal performance of immune system and an over-
expression of anti-inflammatory sequence variants of
immune/inflammatory genes. The data from Sicilian in-
vestigation add another piece to complex puzzle of gen-
etic and environmental factors involved in the control
of life span expectancy in humans, showing a complex
network of trans-inactive genes able to influence the
type and strength of immune responses to environmen-
tal stressors, and as final result, conditioning individual
life expectancy.
The paper of Vasto et al., pays attention on the modifi-
able lifestyle factors such as diet and nutrition to achieve
extension of health span. Previous data reported that in
Sicily, the biggest Mediterranean island, there are some
mountain regions where there is a high frequency of
male centenarians with respect to the Italian average.
The present data show that in Sicani Mountain zone
there are more centenarians with respect to the Italian
average. In fact, in five villages of Sicani Mountains,
there where 19 people with age ranging from 100–
107 years old, on the total population of 18,328 inhabi-
tants. So, the centenarian number was more than 4.32-
fold higher the national average (10.37 vs. 2.4/10,000);
the female/male ratio was 1.1:1 in the study area, while
the national ratio is 4.54:1. Unequivocally, their nutri-
tional assessment showed a high adherence to theMediterranean nutritional profile with low glycemic
index food consumed.
In their paper, Davinelli et al., focus on dietary patterns
of centenarians and nutrient-sensing pathways that have
a pivotal role in the regulation of life span. They point
out that the realization of healthy longevity is possible
but to achieve a longer and a healthier life, increased at-
tention must be placed on lifestyle choices, particularly
the diet. To date the main dietary intervention that may
retard the ageing process is calorie restriction and a typ-
ical example is the Okinawan population in Japan. Many
of the genes that act as key regulators of lifespan also
have known functions in nutrient sensing, thus called
nutrient-sensing longevity genes and variant associated
to longevity have been described.
Conclusion
Success in increasing longevity in laboratory organisms
has shown that ageing is not an immutable process [28].
Hence, the time has come to get more serious about the
effort to slow human ageing or to age successfully. On
the other hand, if ageing is combined with extended
years of healthy life, it could also produce unprecedented
social, economic, and health dividends [29,30]. Thus,
particular attention has been centered on centenarian
genetic background, immune system and life style.
Centenarians, despite being exposed to the same environ-
mental conditions as members of the average population,
manage to live much longer; moreover, as a consequence
of demographic selection, centenarians have a compres-
sion of morbidity and mortality towards the end of their
life-span [31]. On the other hand, it seems that long lived
individuals harbor genetic risk factors for age-related dis-
eases as recently underlined also by genome-wide associ-
ation studies data, reporting as very long lived individuals
share the same number of risk alleles for coronary artery
disease, cancer, and type 2 diabetes than younger controls
from the same population, thus suggesting that human
longevity is not compromised by the cumulative effect of a
set of risk alleles for common disease [32-34]. These stud-
ies support the existence of buffering mechanisms operat-
ing in the determination of human longevity, probably
through the presence of favorable genotypes contrasting
the deleterious effect of age-related disease genes: as a re-
sult, the frequency of deleterious genotypes may increase
among individuals with extreme lifespan because their
protective genotype allows disease-related genes to accu-
mulate [35]. A better understanding of the functional
genes that affect healthy longevity in humans may lead to
a rational basis for intervention strategies that can delay or
prevent age-related diseases. However, with the exception
of APOE and FOXO3A variants, none of the many candi-
date genetic variants tested to date have been consistently
replicated across populations. This is possibly on account
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demographic pressures, making results, as a consequence,
irreproducible [36].
Regarding immunological aspects, studying centenarian
offspring reveal that several B cell immune parameters are
better preserved than in age-matched controls, and
together with their genetic background could contribute
to their healthier ageing. This suggests the idea of the
“familiar youth” of the immune system [37,38].
Concerning life style, it is out of doubt that healthy
centenarians live surrounded by a solid support network
of friends and family. However, diet plays a key role in
successful ageing. Specific dietary factors that may be
involved include a high intake of fruit and vegetables,
and in the property of phytochemicals to activate specific
nutrient sensing pathways. Centenarians have a very high
intake of phytochemicals in the diet. All plants contain
these natural compounds and the elderly have signifi-
cantly lower levels of lipid peroxidation and they suffer
less free-radical-induced damage [39-41]. From a scien-
tific perspective, a particular diet able to delay ageing
may help to identify new molecules to extend and amelior-
ate lifespan, opening new opportunities for drug discovery
and companies working in nutrition and pharmacology. As
recently stated [16], drugs able to mime the effects of
calorie restriction might postpone most age-related diseases.
In this manner, we could get a much greater health bonus
for elderly than overcoming any one definite age-related
disease. It has been calculated, in fact, that the slowdown
of ageing rate by seven years might reduce the age-specific
risk of death and frailty by about half at every age [16,30].
In conclusion, the development of strategies that will
lead to the extension of healthy life and that would result
in slowing the rate of ageing may be part of the new para-
digm for the medical sciences that is the ‘positive biology’.
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